U.S. First Commercial Cannabis Testing Lab Steep Hill Announces Illinois Expansion



BERKELEY, Calif., December 2, 2021 / PRNewswire / – Steep hill, United States’ first commercial cannabis analysis laboratory, expands with new licensed partner in the state of Illinois. In 2019, Illinois became the 11th State to legalize an adult cannabis use program and the 1st state to legalize the use of adults through a law of the state legislature, as well as the medical program established in 2014.

Steep hill, CEO, Nigel stobart, commented: “We are extremely happy to partner with Steep Hill Illinois’ passionate and visionary team. With their success in serial business ventures and their commitment to patient and consumer safety with testing, we believe we will see this group rapidly expand its horizons. ” Soak hill is a leader in cannabis testing, known for consistent quality testing, custom technology and state-of-the-art equipment. The company is dedicated to providing best-in-class customer service and has been the innovation leader advancing a nascent testing industry for the past 13 years.

Steep Hill Illinois is led by a team of experienced and trusted cannabis industry veterans, coupled with successful entrepreneurs, strategists and investors.

Co-founder of strategy and business development, as well as government and regulatory issues Nick etten. Nick, a Illinois native, is a nationally recognized cannabis industry veteran who brings several years of industry experience. Nick recently served on the executive team of Acreage Holdings, a multi-state cannabis operator (MSO), where he led government affairs, policy and strategy as senior vice president of external affairs. . Nick also founded the Veterans Cannabis Project, which focused on changing the conversation about access to cannabis for medical cannabis veterans.

Co-founder John tinsley lead strategy with Nick and focus on business operations, partner relationships, launch of the Illinois laboratory and growth to other markets. John’s comes to the company after two decades of consulting, where he was most recently a partner at EY-Parthenon, a global leader in strategy consulting. His expertise in growth strategy, market development, M&A and operational transformation will be decisive for a successful launch in Illinois.

Co-founder Matt Grabowski lead financial and non-laboratory operations. Matt has successfully launched a number of businesses nationwide in the fitness, health and waste management industries. His experience in business creation, transactions and financial structuring will be invaluable in scaling operations.

Steep Hill Illinois will be available to support the lab and other production activities in 2022. John Tinsley said: “We are currently building the lab, which will be strategically placed in Ottawa, Illinois less than 90 minutes by car from the largest MSOs in Illinois. “Leverage market leaders Soak hill Platform, Steep Hill Illinois will provide the full screen of Illinois regulated tests, including cannabinoids, pesticides, heavy metals, etc. “We will also provide research and development testing services to growers and processors; by supporting our partners in the development of new products and by supporting their growth. ”

For more information, please contact Steep Hill Illinois To: [email protected] or call: (224) 505-5643.

Steep hill is a leading company in the field of cannabis science with imprints in laboratory testing and research and development. Steep hill The foundation was built on the testing and analysis of medical and recreational cannabis to ensure compliance with current safety standards. In 2008, Steep hill opened the first commercial cannabis laboratory in United States. In an effort to help the rest of the world adopt “best practices” in cannabis testing, the company also provides expert advisory services in many parts of the world. Steep hill: “Driving on a global scale. Locally focused. “

For more information visit: www.steephill.com

Contact: Arielle Chu | Telephone: (510) 562-7400 | [email protected]

SOURCE Steep Hill Inc.



Comments are closed.